GNPX 8-K 2026-11-05

Genprex, Inc. (GNPX) 8-K dated 2026-11-05 — accession 0001437749-26-035077.

Genprex, Inc. (GNPX) is a biotechnology company listed on NASDAQ.

Genprex, Inc. filed a 8-K on 2026-11-05. Accession 0001437749-26-035077.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GNPX revenue for 2024-12-31 was $0. Net income was -$21.1M. GNPX currently screens at market cap $5.3M.

Not investment advice. The GNPX SEC hub lists recent forms. The stock page is the research view.